Mark Hvistendahl

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center

Christopher F. Brandt, Mark Hvistendahl, Rahim M. Naimi et al. · Journal of Parenteral and Enteral Nutrition · 2016 · 100 citations

Agriculture, Health Sciences, Nutrition +12

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 75 citations

Medicine, Endocrinology, Pharmacology +8

Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open‐Label Pilot Study

Mark Hvistendahl, Christopher F. Brandt, Siri Tribler et al. · Journal of Parenteral and Enteral Nutrition · 2016 · 72 citations

Medicine, Pharmacology, Surgery +16

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: Catheter‐Related Complications Over 4 Decades at the Main Danish Tertiary Referral Center

Christopher F. Brandt, Siri Tribler, Mark Hvistendahl et al. · Journal of Parenteral and Enteral Nutrition · 2016 · 57 citations

Medicine, Preventive Medicine, Parenteral Drug Delivery +15

Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trial

Johanna Eliasson, Mark Hvistendahl, Nanna Freund et al. · Journal of Parenteral and Enteral Nutrition · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14